Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Dirk Thye$44.5M
Market Cap • 25/04/20242012
(há 12 anos)
2019
(5 years ago)
NASDAQ
Listagem
South San Francisco
Sede • California21
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
QNCXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.